{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:39:52Z","timestamp":1761860392377,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.pathol.2023.01.010","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T13:23:35Z","timestamp":1679405015000},"page":"538-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of glutamic acid decarboxylase (GAD) 65 antibody detection methods for neurological and diabetic investigation in an Australian diagnostic laboratory"],"prefix":"10.1016","volume":"55","author":[{"given":"Amelia","family":"Cecchin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4103-6953","authenticated-orcid":false,"given":"Syed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-6312","authenticated-orcid":false,"given":"Pravin","family":"Hissaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2023.01.010_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pathol.2023.01.010_bib2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","article-title":"Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy","volume":"71","author":"Arino","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.pathol.2023.01.010_bib3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0166-2236(91)90044-U","article-title":"Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus","volume":"14","author":"Solimena","year":"1991","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pathol.2023.01.010_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2023.01.010_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pathol.2023.01.010_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14734220309432","article-title":"Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies","volume":"2","author":"Vianello","year":"2003","journal-title":"Cerebellum"},{"key":"10.1016\/j.pathol.2023.01.010_bib7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1073\/pnas.89.6.2115","article-title":"Two human glutamate decarboxylases,65-kDa GAD and 67-kDa GAD, are each encoded by a single gene","volume":"89","author":"Bu","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2023.01.010_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0168-8227(96)01248-X","article-title":"Detection of recombinant GAD65 and GAD67 antibodies using a simple radioimmunoassay","volume":"32","author":"Kawasaki","year":"1996","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.pathol.2023.01.010_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/08916939409009534","article-title":"Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes","volume":"19","author":"Luhder","year":"1994","journal-title":"Autoimmunity"},{"key":"10.1016\/j.pathol.2023.01.010_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/347151a0","article-title":"Identification of the 64 K autoantigen in insulin-dependant diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase","volume":"347","author":"Baekkeskov","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2023.01.010_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2018.01.007","article-title":"Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: a comparison of anti-GAD antibody titres and time-dependant changes between neurologic disease and type 1 diabetes mellitus","volume":"317","author":"Nakajima","year":"2018","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.pathol.2023.01.010_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.180.2.595","article-title":"Higher autoantibody levels and recognition of a linear NH2 - terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependant diabetes mellitus","volume":"180","author":"Kim","year":"1994","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pathol.2023.01.010_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000696","article-title":"Neurologic syndromes related to anti-GAD65: clinical and serologic response to treatment","volume":"7","author":"Munoz-Lopetegi","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.pathol.2023.01.010_bib14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1212\/WNL.57.5.780","article-title":"Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies","volume":"57","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pathol.2023.01.010_bib15","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Salz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pathol.2023.01.010_bib16","first-page":"353","article-title":"GAD antibodies in neurological disorders \u2013 insights and challenges","volume":"16","author":"Graus","year":"2020","journal-title":"Nature"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523000892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523000892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:29:50Z","timestamp":1758472190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302523000892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0031302523000892"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2023.01.010","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of glutamic acid decarboxylase (GAD) 65 antibody detection methods for neurological and diabetic investigation in an Australian diagnostic laboratory","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2023.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}